Company page

Telix Pharmaceuticals Limited

Telix Pharmaceuticals Limited, trading under the ticker TLX, is a public company based in Australia with a market capitalization of approximately AUD 3.71 billion. The company focuses on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer and other serious diseases. Telix aims to improve patient outcomes through its targeted therapies and continues to advance its product pipeline in the healthcare sector.